LOVE Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $256,448.49
Insider Selling (Last 12 Months): $0.00

Cannara Biotech Insider Trading History Chart

This chart shows the insider buying and selling history at Cannara Biotech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cannara Biotech Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 07/10/2020 01:00 AM ET

This chart shows the closing price history over time for LOVE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cannara Biotech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/12/2024Nicholas SosiakSenior OfficerBuy10,704$0.71$7,599.84
12/10/2024Donald John OldsDirectorBuy25,000$0.78$19,400.00
8/21/2024Olymbec Investments Inc.InsiderBuy120,500$0.76$92,049.95
8/15/2024Olymbec Investments Inc.InsiderBuy63,500$0.69$43,700.70
8/14/2024Donald John OldsDirectorBuy20,000$0.62$12,400.00
7/26/2024Nicholas SosiakSenior OfficerBuy3,916$0.60$2,349.60
7/26/2024Olymbec Investments Inc.InsiderBuy48,000$0.63$30,048.00
5/21/2024Olymbec Investments Inc.InsiderBuy6,000$0.82$4,920.00
5/17/2024Olymbec Investments Inc.InsiderBuy10,000$0.82$8,205.00
5/13/2024Olymbec Investments Inc.InsiderBuy6,000$0.80$4,789.80
5/10/2024Anthony ManoukSenior OfficerBuy4,400$0.74$3,256.00
5/9/2024Donald John OldsDirectorBuy30,000$0.78$23,250.00
5/8/2024Olymbec Investments Inc.InsiderBuy6,000$0.75$4,479.60
2/13/2023Olymbec Investments Inc.InsiderBuy10,300$0.99$10,197.00
11/30/2022Nicholas SosiakSenior OfficerBuy22,700$1.10$24,970.00
8/8/2022Donald John OldsDirectorBuy100,000$0.11$10,750.00512,000
8/3/2022Donald John OldsDirectorBuy200,000$0.10$20,000.00522,220
See Full Table

SEC Filings (Institutional Ownership Changes) for Cannara Biotech (CNSX:LOVE)

Cannara Biotech logo
Cannara Biotech Inc. is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. Leveraging Quebec's low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.
Read More on Cannara Biotech

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

69,070 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Cannara Biotech?

Cannara Biotech's top insider investors include:
  1. Anthony Manouk (Senior Officer)
  2. Donald John Olds (Director)
  3. Nicholas Sosiak (Senior Officer)
  4. Olymbec Investments Inc (Insider)
Learn More about top insider investors at Cannara Biotech.